SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is soaring after its CFO confirmed HBM4 shipments began a quarter early, directly addressing prior "inaccurate reporting" and reiterating that 2026 HBM supply is sold out amidst surging AI demand. The community is abuzz with bullish sentiment and short squeeze predictions as analyst price targets climb on the company's critical role in the memory market.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is experiencing extreme volatility following strong Q2 earnings and an extended partnership with Kioxia, driven by booming AI and data center demand for memory chips; however, the community remains divided between those forecasting a 'memory supercycle' and others predicting an imminent pullback after its parabolic run.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is trending after a perplexing sell-off following strong earnings and upbeat guidance, which many in the community attribute to initial misreporting by news outlets and prior short-seller allegations now retracted; this fuels debate over the stock's valuation versus perceived manipulation.

Berachain

BERA is trending amidst a polarized community debate, with strong bullish sentiment driven by its rapidly growing Total Value Locked (TVL), unique Proof-of-Liquidity model, and ecosystem upgrades, contrasting with bearish concerns over token dilution from unlocks and perceived 'pump and dump' dynamics.

Jack in the Box, Inc. engages in the provision of developing, operating, and franchising a chain of quick-service and fast-casual restaurants. It operates through the Jack in the Box and Del Taco segments. The Jack in the Box segment offers a selection of distinctive products including classic burgers and other product lines such as Buttery Jack Burgers. The company was founded by Robert Oscar Peterson in 1951 and is headquartered in San Diego, CA.

Jack In The Box, Inc.

Jack In The Box is trending following its strategic divestiture of Del Taco to address substantial debt and implement a brand turnaround. This move is sparking intense debate among investors, with some anticipating a recovery and potential short squeeze, while others remain deeply concerned about persistent operational challenges and the company's financial health.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as its oral obesity drug VK2735 is set to advance directly into Phase 3, a move signaling regulatory confidence and accelerating its market pathway. This development, coupled with high short interest, is igniting community speculation about a significant short squeeze and potential acquisition interest from major pharmaceutical companies vying for a share of the burgeoning anti-obesity market.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity Software faces intense pressure after its Q4 report showed an earnings beat but tempered Q1 guidance, fueling a massive sell-off. The community is fiercely debating whether this steep drop is an overreaction and a buying opportunity, or a reflection of underlying concerns about AI competition and future growth.

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Sanofi - ADR

Sanofi-Aventis

Sanofi is trending following its recent completion of the Dynavax acquisition, which expands its vaccine portfolio and includes a licensed oral COVID-19 vaccine, as investors also weigh other pipeline updates like new eczema drug data and regulatory milestones, alongside continuous speculation for further strategic M&A in the broader biotech sector.

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical, Risk, Legal Exhibitions and Print & print-related. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity. The Risk segment provides customers with solutions and decision tools that combine public and industry specific content with advanced technology and analytics to assist them in evaluating and predicting risk and enhancing operational efficiency. The Legal segment is a global provider of legal, regulatory and business information and analytics that helps customers increase productivity, improve decision-making and outcomes and advance the rule of law around the world. The Exhibitions segment is an event business, enhancing the effect of face-to-face through data and digital tools. The Print & print-related segment consistent with financial information provided to the board. The company was founded by Albert Edward Reed in 1903 and is headquartered in London, the United Kingdom.

RELX Plc - ADR

RELX is experiencing a significant sell-off driven by market concerns over new AI legal plug-ins from Anthropic's Claude and OpenAI Frontier, sparking fears of disruption in the legal and IT sectors. However, the community largely views this as an overreaction, highlighting RELX's strong fundamentals, irreplaceable data moat, and its strategic position as a high-quality AI data play currently seen as deeply oversold.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingo is trending amid fears its core business faces obsolescence due to new AI translation services from companies like T-Mobile, prompting a sharp sell-off. While the community is divided, many argue that learning a language is distinct from translation and highlight Duolingo's brand strength and expansion into new subjects.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Precision IBD is a Biotechnology company and operator of a drug development precision medicine company intended to develop therapeutics for inflammatory bowel diseases.

Prometheus Biosciences Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $COIN earnings on Thursday?

RXDX
Prometheus Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RXDX News

RXDXPrometheus Biosciences Inc